Newsroom | 85943 results

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...

UPPER NYACK, N.Y.--(BUSINESS WIRE)--Report shows drug pricing reform can cost patients more...

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) announced today that Daniel Pinto, President, JPMorganChase, has been elected to its Board of Directors. “We are thrilled to have Daniel join Johnson & Johnson’s Board of Directors,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. “He is an exceptional leader with deep financial expertise and understanding of global capital markets. Daniel’s unique perspective and wealth of experience wi...

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the Compensation Committee of the Company’s Board of Directors granted two new employees options to purchase a total of 8,400 shares of the Company’s common stock at an exercise price per share of $9.85, which was the closing price on June 9, 2025, and restri...

CAMBRIDGE, Massachusetts--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), la compañía líder en terapias de ARN de interferencia (ARNi), ha anunciado hoy que la Comisión Europea (CE) ha concedido la aprobación para el tratamiento de la amiloidosis de transtiretina común o hereditaria en pacientes adultos con cardiomiopatía (ATTR-CM) como indicación adicional para su terapia huérfana de ARNi AMVUTTRA® (vutrisiran). El comunicado en el idioma original es la versión oficial y autoriz...

BOSTON--(BUSINESS WIRE)--20/20 Onsite, the leading provider of point-of-need ophthalmic services for clinical trials, announces the deployment of its latest mobile vision clinic, bringing its fleet to 16 units, including a mix of mobile clinics, pods, and suites. The new unit hit the road in early May and is now fully operational, enabling 20/20 Onsite to support a higher tempo of decentralized and hybrid clinical trials nationwide. This milestone reinforces 20/20 Onsite’s ability to scale with...

NEW YORK--(BUSINESS WIRE)--EDETEK Inc., a global provider of leading AI-driven clinical development platforms and services, has engaged Capgemini to support its ongoing advancements in digital transformation within the life sciences industry. This engagement combines EDETEK’s deep domain expertise and established platforms and services with Capgemini’s advanced AI and engineering capabilities, to enable EDETEK to deliver innovative solutions aimed at optimizing clinical development, improving o...

CHARLESTON, S.C.--(BUSINESS WIRE)--Winyah Pharmacy and Preferred Care rebrand as Guardian Pharmacy of South Carolina, and open new high-tech Charleston headquarters....

SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs—a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics—today announced BioSeeker™, a next-generation AI discovery engine redefining how the world identifies and treats disease. It powers Seek Labs’ proprietary Programmable Target Ablation Platform (PTAP), a CRISPR-based system engineered to target and cleave exact genetic sequences required for pathogens to replicate, sp...

CAMBRIDGE, England--(BUSINESS WIRE)--Enhanced Genomics (‘Enhanced’ or ‘the Company’), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced the appointment of Dietrich Stephan, Ph.D. as Chair of the Board of Directors. In this role, Dr. Stephan will lead the management team in implementing the Company’s strategic plans, including driving expansion of its internal target identification pipe...